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FK 506: Effects on glomerular hemodynamics and on mesangial cells in
culture. FK 506 is a new immunosuppressive drug that, like cyclosporine
A (CsA), presents nephrotoxicity. Glomerular hemodynamic studies
showed that acute FK 506 infusion (N = 9, 3 mg/kg body wt, iv. in bolus)
caused a 57% reduction in glomerular filtration rate (GFR) (0.74 0.03
to 0.32 0.02 mI/mm, P < 0.05) and a 40% reduction in single nephron
glomerular filtration rate (SNGFR; 43.0 5.2 to 26.0 2.5 ni/mm, P <
0.05) due to a 25% reduction in glomerular plasma flow rate (QA) (133.4
19.8 to 99.8 12.0 ni/mm) and a 22% reduction in glomerular
ultrafiltration coefficient (Kf; 0.1009 0.0203 to 0.0790 0.0130 nI/sec
mm Hg). After 10 days of FK treatment (N = 8, 0.6 mg/kg body wt, i.p.),
we observed a reduction of 23% in GFR (0.97 0.02 to 0.75 0.04
mi/mm, P < 0.05) and of 23% in SNGFR (37.9 3.0 to 29.1 1.9 ni/mm,
P < 0.05) due to a 42% reduction in I(f (0.1486 0.0101 to 0.0870
0.01 10 nI/sec mm Hg, P <0.05) and a 38% reduction in QA (117.6 10.2
to 73.5 6.1 nI/mm, P < 0.05). The latter was consequent to the
increment of 72% in total arteriolar resistance (RT) (3.1 0.2 to 5.2 0.5
0.5 1010 dyn sec cm5, P < 0.05).Thus, the pattern of FK 506 effect
on glomeruiar hemodynamics was similar in both acute and chronic
treatments. Additionally, in order to evaluate the effect of FK 506 on
mesangial cells (MC), we performed studies measuring intracellular
calcium concentration ([Ca2]) with Fura-2/AM as well as MC contrac-
tion by morphometric analysis. It was observed that FK 506 increases the
[Ca2]1 (R 340/380: 2.5 0.3 to 3.8 0.4, P < 0.05) due to mobilization
of the extracelluiar calcium pooi, via opening calcium type L voltage
dependent channels, since verapamil blunted the increases of [Ca2}
caused by FK 506 (R 340/380: 3.5 0.9 to 2.8 0.8). The [Ca2]1 was not
changed after FK 506 incubation of MC with verapamil and thapsigargin,
and thus no calcium release-activated channel (CRAC) was affected. The
increase of [Ca2] induced by FK 506 probably caused contraction of MC
evaluated by reduction of the cross sectional area from 3772 106 to 1912
61 rm2 (P < 0.05). Thus, FK 506 caused a reduction in SNGFR by
reducing QA and Kf after both acute and chronic administration, and the
mesangial cells potentially participate in this nephrotoxicity via reduction
in Kf, mainly during chronic treatment.
FK 506 (FK) is a new immunosuppressive drug that, like
cyclosporine A (CsA), presents side effects including nephrotox-
icily. Functionally, both drugs induce acute renal failure due to
reduction in renal plasma flow (RPF) and in glomerular filtration
rate (GFR) [1—5]. The hemodynamic events related to FK may
include the vasoconstriction of glomerular arterioles, the libera-
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tion of vasoactive substances and the contraction of mesangial
cells (MC) [1—3, 6, 71. Additionally, the cellular events triggered
by FK and CsA seem to be similar. The nonspecific action of these
drugs on the immune system cells results from the interaction with
intracellular receptors, generically recognized as immunophilins.
Cyclophilin and FK-binding protein (FKBP) are the immunophi-
lins used for CsA and FK, respectively. The common target for
both complexes is the calcineurin present in many cells [8, In
vitro, calcineurin binds to the FK-FKBP complex in a Ca2-
dependent manner. Thus, FK blocks a Ca2 4-dependent signaling
step that normally leads to nuclear transport of a cytoplasm
subunit of nuclear factor activated T cells (NF-AT) which is one
of many transcription factors required for antigen-induced gene
expression [9]. It is known that FK binding protein is found in
many live cells from different animal species and thus FK may
potentially interfere with these cells, explaining the side effects
observed.
The contraction of MC induced by the increases of intracellular
calcium concentration ([Ca2]) causes a decrease in glomerular
surface area and in glomerular ultrafiltration coefficient (Kf); thus
it could be a potential determinant of nephrotoxicity in animal
studies [10—13].
Although many effects of FK have been clarified, its actions on
the renal microcirculation and on MC have not yet been evalu-
ated. Thus, the objective of the present investigation was to study
glomerular hemodynamics during acute and chronic treatment
with FK and to determine the action of the drug on [Ca2I and on
MC surface area.
Methods
Hemodynamic studies
Studies were performed on four groups of adult male Munich-
Wistar rats weighing 200 to 300 g. Group 1 (N = 5) received an
acute infusion of FK vehicle, cremophor and isopropiiic alcohol
i.v. for five minutes. Group 2 (N = 9), received FK, 3 mg/kg body
wt, i.v., in bolus (Fujisawa Pharmaceutical Co., Ltd., Osaka,
Japan). Parameters of whole kidney function and giomerular
hemodynamics were measured before and after the acute infu-
sions. The third group (Group 3, N = 8) and the fourth group
(Group 4, N = 9) received chronic i.p. administration of FK
vehicle or FK, 0.6 mg/kg body wt, for 10 days, respectively. After
10 days the animals were submitted to experimental studies to
evaluate whole kidney function and glomerular hemodynamics.
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Micropuncture studies were performed in all rats following the
usual routine methods [11, 12, 14]. Each rat was allowed free
access to water and a standard rat pellet diet until the morning of
the study. Rats were anesthetized with mactin (BYC Gulden,
Konstaz, Germany), 100 mg/kg body wt, i.p. and placed on a
heated animal board in order to maintain rectal temperature close
to 37°C. Following tracheotomy, a polyethylene catheter (PE-50)
was introduced into the left femoral artery and connected to a
direct-writing recorder (Gould model 2200, Cleveland, OH, USA)
for mean arterial pressure (MAP) measurements and collection of
blood samples. Approximately 60 .d of arterial blood was col-
lected for baseline hematocrit (Hct) and protein (CA) measure-
ments. The left jugular vein was catheterized (PE-50) for infusion
of inulin (10%) and p-aminohippuric acid (PAH) (2%) at a rate of
1.2 ml/hr, and the catheter was maintained throughout the
experiment to determine glomerular filtration rate (GFR) and
total renal plasma flow rate (RPF). The right jugular vein was
catheterized (PE-50) for infusion of isoncotic rat serum to replace
loss of liquids during surgery and to maintain Hct at preoperative
levels [15]. The infusion rate was 10 ml/kg/hr for 45 minutes and
was then reduced to 1.5 ml/kg/hr for the remainder of the
experiment. After laparotomy, a catheter (PE-lO) was inserted
into the left ureter for urine collection and flow rate (V) deter-
mination. After a 45-minute equilibration period, the initial study
period was started. Two urine and blood samples were collected
for determination of Hct, CA, inulin and PAR in plasma and
urine, and the procedure was repeated during the second study
period.
Samples of fluid surface proximal tubules were collected for
determination of flow rate and inulin concentration, followed by
calculation of single nephron glomerular filtration rate (SNGFR).
Hydraulic pressures were measured in surface glomerular capil-
laries (PGC), proximal tubules (PT), efferent arterioles (PEA) and
peritubular capillaries (Pa) with a continuous recording servonull
micropipette transducer system (1PM Inc., San Diego, CA, USA).
The results are reported as mean SEM. To estimate the pre- and
postglomerular colloid osmotic pressures, A and irE, protein
concentration in femoral arterial (CA) and efferent arteriolar (CE)
plasma were measured as described previously [16]. These esti-
mations permitted the calculation of single nephron filtration
fraction (SNFF), initial glomerular capillary plasma flow rate
(QA), afferent (RA), efferent (RE) and total arteriolar resistance
(RT) and glomerular ultrafiltration coefficient (I(f), using equa-
tions previously described [16, 17]. Data were corrected for the
left kidney weight in grams. The total renal vascular resistance
(TRVR) was calculated according to the formula TRVR (MAP
— 3)/[RPF/(1 — Hct)] [141.
Analytical procedures. Plasma and urinary inulin concentrations
were determined by the macroanthrone method of Fuhr, Kacz-
marczyk and Kruttgen [18]. PAH concentration was determined
by the method of Smith et al [19]. Inulin concentration in tubular
fluid was measured by the microfluorescence method [20]. Protein
concentrations in efferent arteriolar and femoral arterial plasma
were determined by the fluorimetric method [21]. Whole kidney
filtration fraction (FF) was calculated as the GFR/RPF ratio.
At the end of the functional studies the kidneys from the
chronic groups were fixed by intravascular perfusion of a solution
containing phosphate-buffered 2% glutaraldehyde, pH 7.2 [22].
Paraffin-embedded tissue was cut into 3 to 5 m sections which
were stained with H.E., PAS and Masson trichrome and examined
by light microscopy.
Mesangial cell culture
Materials. RPM! 1640, collagenase Ia, fetal calf serum, penicil-
lin G, glutamine, acid HEPES, bovine albumin, trypsin, vera-
pamil, thapsigargin, digitonin, manganese, EGTA and fibronectin
antibody, actin, myosin, collagen IV, citokeratin and factor VIII
were obtained from Sigma Chemical Company (St. Louis, MO,
USA). Fura-2/AM was obtained from Molecular Probe (OR,
USA) and FK 506, Tacrolimus®, was a gift from Fugisawa
Pharmaceutical Co. Ltd. (Osaka, Japan).
Methods. The glomeruli were isolated from Wistar rats by the
method of Greenspon and Krakower [23]. Briefly, rats were
anesthetized with sulfuric ether and submitted to bilateral ne-
phrectomy. The separated cortex was sliced and forced through a
graded series of stainless steel meshes, and isolated uncapsulated
glomeruli were recovered. MC were obtained from collagenase-
treated isolated glomeruli in order to remove the epithelial cell
component. Washed glomerular remnants were plated at a den-
sity of about 300 glomeruli/cm2 onto RPM! 1640 supplemented
with 20% fetal calf serum, 50 U/ml penicillin, 2.6 g acid HEPES
and 2 mrvi glutamine. Culture flasks were kept in a 95% air, 5%
CO2 humidified environment at 37°C. The medium was replaced
every 36 hours. After three weeks in primary culture, MC were
harvested with trypsin. Subcultures were grown in the same
medium. These cells were characterized by the following criteria:
(a) morphological appearance of stellate cells; (b) immunofluo-
rescence staining of the extracellular matrix for type IV collagen
and fibronectin using monospecific antiserum; (c) negative immu-
nofluorescence staining for human factor VIII antigens and
citokeratin; and (d) positive immunofluorescence staining for
actin and myosin monospecific antiserum. In parallel experiments,
cell viability was monitored with Trypan blue and was observed to
be about 95%.
[Ca2] determination. Cultures in 3rd passage were treated with
0.05% trypsin after 24 hours in fetal bovine serum free medium
and resuspended in Tyrode solution containing 0.2% bovine
albumin. The cell suspension was left to stand for 60 minutes in a
CO2 incubator at 37°C. [Ca2]1 was measured ratiometrically after
loading the cells with the Ca2-sensitive dye Fura-2 using a SPEX
fluorimeter (AR CM System, NJ, USA). Cells were centrifuged
and resuspended in albumin-free Tyrode. A 2.5 ml volume with
106 cells/cm3 was transferred to a quartz cuvette and submitted to
constant stirring at 37°C in a fluorimeter calibrated with excitation
at two different wavelengths (340 and 380 nm) and 505 nm
emission. Cell autofluorescence was first measured and consid-
ered to be negligible when lower than 10%. Cells were later
incubated with Fura-2/AM (2 LM) for three hours before the
beginning of the experiment. After analysis of the fluorescence
spectrum to confirm appropriate indicator loading, the cells were
washed with Tyrode, resuspended in fresh solution and placed in
quartz cuvettes. Six groups were studied for FK action on MC.
The effect of FK vehicle was first tested on Fura-2/AM fluores-
cence and on [Ca2]. Both were negative and permitted contin-
uation of the experiment.
Group I (N = 8): We analyzed five doses (D) of FK successively
given after stabilization: D1, iO M; D2, 2 X iO M; D3, 4 X iO
D4, 5 X i0 and D5, 10—6 M.
Group 2 (N = 4): The effect of successive doses of FK (D1, iO
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Table 1. Summary of general parameters and whole kidney function in the acute groups before and after infusion of vehicle (VEH) or
FK-506 (FK)
Group
BW KW
g
MAP
mm Hg
Hct
%
v
j.d/min
GFR RPF FF
%
TRVR
mm Hg• mm/mimI/mm
Acute VEH (N = 5)
before — — 116
2
49
1
4.0
0.5
0.80
0.01
2.28
0.87
35
1
24
1
after 259
12
0.84
0.06
110
2
49
1
3.9
0.5
0.76
0.02
2.21
0.06
36
1
24
1
Acute FK (N = 9)
before — — 102
2
48
1
3.0
0.5
0.74
0.03
2.05
0.08
36
1
22
1
after 247
5
0.96
0.02
99
3
48
2
2.7
0.6
0.32a
0.02
0.84k'
0.06
36
3
54
6
Data are X SEM.
aP < 0.05 after vs. before
M; D2, 2 X iO D3, 4 x i0 M; D, 5 X i0 and D5, 106
M) on [Ca2]1 was studied after incubation with verapamil (VP, 5
x iO M) for 10 minutes.
Group 3 (N = 4): The effect of successive doses of FK(DJ, i0
M; D2, 2 X i0 M; D, 4 X iO M; D, 5 X i0 and D5, 10_6
M) was evaluated on MC in Ca2-free buffer. After the last dose
of FK, CaCl2 was added to the solution in order to obtain a final
concentration of 1.36 m in the bath and fluorescence was
recorded again. After stabilization of the curve a new dose of 1.36
m calcium was added, increasing the bath final concentration to
2.7 mM.
Group 4 (N = 3): The effect of 106 M FK was evaluated after
incubation of MC with thapsigargin (TSG, 2 /.LM) in a solution with
normal calcium values.
Group 5 (N = 2): The protocol was the same as for Group 4(FK 106 M) except that the MC were tested in calcium-free
Tyrode solution with TSG added. After this effect was recorded,
two successive doses of 1.36 ifiM CaC12 separated by a period of
stabilization were added, and a further FK in maximal dose was
also added.
Group 6 (N = 2): The action of FK (106 M) was evaluated
after incubation with TSG and VP in a calcium-free MC suspen-
sion. Again, two successive doses of 1.36 m calcium were added
and a further FK in maximal dose was also added.
At the end of each experiment, the effect of digitonin, Mn and
EGTA was evaluated for control of the preparation. The results
are presented as the 340/380 ratio and when necessary this ratio
was transformed in order to provide the calcium concentration as
described by Grynkiewicz et al [24].
Morphometty
Mesangial cells were evaluated morphometrically after 10 min-
utes incubation with the maximum FK dose (10—6 M) and after
staining with acridine orange. Cells were then photographed and
the measurements calculated on a digital board using the Sigman-
scan software (Sigmanscan®, Jandel Scientific, Sausalito, CA,
USA). The calibration was done according to photograph magni-
fication. Results are reported as j.m2 and were compared in terms
of percent modification of the area in comparison to the control.
A > 10% reduction in area in relation to the control was
considered to represent cell contraction [25].
Statistical analyses
Data for in vivo studies are presented as mean (X) SEM. Data
for whole kidney function were normalized for left kidney weight
in grams. Statistical analyzes for global and hemodynamic studies
were performed by Student's paired and unpaired t-test. Statistical
significance was defined as P < 0.05. For in vitro studies with
mesangial cells, the results were analyzed by the Wilcoxon test for
group 1, with P < 0.05 considered to be significant. Results
obtained for intracellular calcium were expressed as the mean of
the 340/380 ratios. Data for groups 2, 3 and 4 were analyzed by
Friedman two-way rank analysis of variance [26], with P < 0.05
considered to be significant. For groups 5 and 6, no statistical tests
were utilized.
The morphometric data were analyzed by the Mann Whitney
test for unpaired data obtained before and after incubation with
the maximal FK dose. A P < 0.05 was considered significant.
Results
Table 1 shows general and whole kidney function parameters in
the acute groups, before and after infusions of FK or FK vehicle.
Acutely administered FK vehicle (Group 1) did not change MAP,
V, GFR, RPF, FF or TRVR. Conversely, the acute infusion of FK
(Group 2) induced an important decline in GFR (57%) and RPF
(59%) (Fig. 1). The filtration fraction (FF) remained stable and
TRVR increased 2.5 times. Table 2 shows the glornerular hemo-
dynamic parameters obtained for group 2 (acute FK). This
evaluation was not performed for acute infusion of FK vehicle,
since whole kidney function was not altered by this treatment
(shown in Table 1). FK provoked a significant (P < 0.05) 40%
decline in single nephron GFR (SNGFR) and nonsignificant
reductions in 0A (25%) and Kf (22%). Total arteriolar resistance
(RT) was only slightly increased (13%) and no significant alter-
ations were observed in glomerular or tubular hydraulic pressures.
In the chronic FK group (Table 3), reductions in GFR (23%, P
<0.05, compared with FK vehicle) and RPF (29%, P < 0.05 vs.
vehicle) were observed. TRVR increased slightly (32%, P < 0.05)
and FF remained stable. The micropuncture studies (Table 4)
showed that chronic FK induced a decline in SNGFR (23%, P <
0.05), in 0A (38%,P < 0.05) and in Kf (41%, P < 0.05), compared
with vehicle. The reduction in 0A occurred as a result of an
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Fig. 1. Comparative (z%) hemodynamic effects before (pre, U) and after(after, U) acute and chronic FK 506 administration. *P < 0.05 vs. pre-FK.
elevation in both arteriolar resistances, RA (55%, P < 0.05) and
RE (100%, P < 0.05). No effect of chronic FK was observed on
mean glomerular hydraulic pressure (PGC) or on tubular hydraulic
pressure (PT).
Morphological studies using light microscopy revealed no alter-
ation in the glomeruli, tubules, vessels or interstitial compartment.
Data obtained for intracellular calcium were expressed as the
mean of the 340/380 ratios since this index presents a lower
variability than the concentration in molarity and thus provides
more reliable results. Figures 2 to 7 were constructed on basis of
this ratio, and the results are also calculated in molarity and
presented in the text.
When the action of FK on MC was studied, it was observed that
FK caused increases in [Ca2]1 in all experiments in group 1 (R
340/380: 2.5 0.3 vs. 3.8 0.4, N = 10, P < 0.02). A typical
experiment is shown in Figure 2, where [Ca2]1 varied from 85 nM
(basal) to 109 flM (in the presence of 106 M of FK). However,
these [Ca2]1 increments were blunted when a channel blocker
(verapamil) was used (Group 2, R 340/380, 3.5 0.9 to 2.8 0.8),
as shown in Figure 3 (261 flM vs. 249 nM). When the MC
suspension was studied in the Ca2-free buffer, the levels of
[Ca2] were maintained after FK administration (Group 3, R
340/380, 1.5 0.3 vs. 1.4 0.3). However, when CaC12 was added
to the extracellular medium, an increase in [Ca2]1 (R 340/380: 1.4
0.3 to 2.2 0.5, P < 0.05) was observed without an additional
FK dose. Figure 4 shows a typical experiment with a basal [Ca2]
of 3 flM, reaching 41 n after the addition of CaCI2 (final bath
concentration of 1.36 mM). The [Ca2J1 did not change even when
additional 1.36 mM CaC12 was added to the bath (final concentra-
tion of 2.7 mM). This observation suggests that FK acts on the
cellular membrane and the increase of [Ca2]1 depends on the
presence of extracellular Ca2. To determine if the effects of FK
on [Ca2J are related to Ca2-release-activated channels
(CRAC), we used thapsigargin (TSG), an inhibitor of Ca2-
ATPase of the endoplasmic reticulum (ER) membrane [27].
Figure 5 exemplifies an experiment using thapsigargin. The addi-
tion of TSG provoked a slow and progressive increase in fluores-
cence, reaching a maximal value (phase "a" from 60 n to 124 nM)
(Group 4, R 340/380, 1.7 0.03 to 2.2 0.15). Phase "a" was
followed by a decrease in fluorescence without returning to
baseline (phase "b" [Ca2], 80 nM; and R 340/380, 2.2 0.15 to
2.1 0.12) as a consequence of an influx of Ca2 via CRAC. This
influx probably was stimulated by the depletion of Ca2 from ER,
as suggested by Takemura et al [27], observed in different cells.
After this phase, the maximal dose of FK was given (10—6 M;
phase "c"), and a progressive and slow decrease in the intensity of
fluorescence was observed in the direction of baseline values
([Ca2], 77 nM; R 340/380, basal x FK 1.70 0.03 vs. 2.13 0.09,
P < 0.05), suggesting that FK was not able to activate additional
channels. Figure 6 shows that TSG in the absence of extracellular
Ca2 caused a progressive and slow increment in fluorescence,
but of lower intensity when compared with the experiment with
normal extracellular calcium concentration (Fig. 5). The addition
of CaC12 to the solution (1.36 mM) caused an increase of the initial
value (from 38 n to 112 nM), and a further increment (to 148 nM)
was observed when an additional dose of Ca2 was added to the
solution (final concentration of 2.7 mM). The later addition of
10—6 M FK caused a further increment in [Ca2]1 (to 184 nM),
suggesting that FK acts on channels other than CRAC. Figure 7
shows a protocol similar to that illustrated in Figure 6, except in
the presence of verapamil. In the presence of thapsigargin the
maximum value of 121 n was reached. With the addition of
calcium to the bath, first to a concentration of 1.36 m and later
to double this value (2.7 mM), the [Ca2] changed from 91 n to
252 n and 314 nM. Verapamil had no blocking effect on CRAC,
but inhibited the FK effect, since when it was added, the [Ca2]1
decreased to 250 nM. In this situation, after addition of extracel-
lular calcium, an increase in [Ca2]1 due to a calcium influx via
CRAC was observed and, when FK was added, it was not able to
further increase {Ca2]. These data suggest the dependence of
the action of FK on the voltage-dependent channels in MC.
Therefore, our results suggest that FK increases [Ca2] by acting
on voltage-dependent channels without stimulating CRAC. Ad-
ditionally, FK was able to cause contraction of MC (Fig. 8) by a
50% reduction in cross-sectional area (CSA) from 3772 106 to
1912 61 jim2 (P < 0.05).
Discussion
FK is a liposoluble macrolide antibiotic, isolated from the
fermentation broth of a soil fungus named Streptomyces tsuku-
baiensis [28]. Like CsA, it inhibits T cell activation and lympho-
kine production in vitro and suppresses both cell-mediated immu-
nity and allograft rejection in experimental animals [29, 30]. FK
has been widely used as an immunosuppressor in human trans-
plantation since 1989 [31], but a number of side effects have been
described, with nephrotoxicity being the main undesirable effect
whose cause has not been completely determined [1, 2, 7, 32, 33].
In the present study, the acute administration of FK provoked
an important fall in total glomerular filtration rate (GFR) due to
a decrease in total renal plasma flow rate (RPF), consequent to
the increase in mean total vascular renal resistance (TRVR). The
micropuncture studies showed that the reduction of 40% in single
nephron glomerular filtration rate (SNGFR) was the result of a
combination of a 25% decline in glomerular plasma flow rate
(QA) and a 22% decline in glomerular ultrafiltration coefficient
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Table 2. Glomerular hemodynamic parameters in the acute FK group
SNGFR QA SNFF RA RE RT GC T E
Group nt/mm % x1O'° dyn sec cm5 mm Hg nI/s mm Hg Eq/Dis
Acute FK (N = 9)
before 43.0 133.4 37 2.2 1.3 3.5 42 12 30 30 0.1009 6/3
5.2 9.8 1 0.4 0.4 0.3 1 1 1 1 0.0203
after 26.0 99.8 28 2.6 1.5 4.1 41 12 29 29 0.0790 4/5
2.5 12.0 1 0.4 0.3 0.8 1 1 1 1 0.0130
Data are X SEM. Abbreviations are: Eq, equililibrium; Dis, disequilibrium.
a P < 0.05 after vs. before
Table 3. Summary of general parameters and whole kidney function in the chronic groups: Vehicle (VEH) and FK
Body wt
in fn Kidney wt GFR RPF
MAP Hct V FF TRVR
Groups g mm Hg % pi/min mI/mm % mm Hg mm/mI
Chronic VEH 242 254 0.83 99 45 4.8 0.97 2.80 38 20.3
(N = 8) 11 11 0.03 1 1 1.0 0.02 0.30 1 2.0
Chronic FK 220 220 0.78 92 41 4.1 0.75a 1.98a 38 26.8a
(N = 8) 4 6 0.04 2 2 0.6 0.04 0.11 1 1.7
Data are X SEM. Abbreviations are: in, initial; fn, final.
a P < 0.05 FK vs. VEH
Table 4. Glonierular hemodynamic parameters during chronic administration of Vehicle (VEH) or FK
SNGFR QA SNFF RA RE RT GC 'T E K
Group nt/mm % X10'° . dyn sec cm5 mm Hg nI/sec mm Hg Eq/Dis
Chronic VEH 37.9 117.6 32 2.2 0.9 3.1 42 17 25 29 0.1486 6/2
(N = 8) 3.0 10.2 1 0.1 0.1 0.2 1 1 I 1 0.0101
Chronic FK 29.la 735 4oa 34a 5.2 43 17 26 31 0.0870a 6/2
(N = 8) 1.9 6.1 1 0.4 0.2 0.5 2 1 2 1 0.0110
Data are X SEM. Abbreviations are: Eq, equilibrium; Dis, disequilibrium.
a P < 0.05 FK vs. VEH
(Kf), since the transglomerular hydraulic pressure difference (zP)
was unchanged (Fig. 1). The reduction in 0A was due to a slight
(17%) increase in total arteriolar resistance (RT). Although the
decline in I( was not significant, one should consider that a larger
number of animals were in filtration pressure equilibrium during
the control period, before FK (6/3), allowing the calculation of
only a minimum Kf. This ratio was shifted to 4/5 after FK
administration, that is, more than 50% of animals reached the
disequilibrium filtration pressure, permitting the calculation of
unique Kf values. Thus, in the acute group, during the control
period the calculated Kf could be lower than the actual value.
Despite these quantitative differences, the glomerular hemody-
namic pattern induced by FK is similar after acute or chronic
treatment. In contrast, in our laboratory we have observed distinct
patterns for acute and chronic CsA treatment [4, 5].Acutely, CsA
at a dose of 50 mg/kg i.v. caused a decrease in °A by increasing
RA but also caused an impressive increase in RE, thus elevating
Gc (Fig. 9). The acute effect of CsA caused a decrease in Kf. In
contrast, short-term (9 days) chronic CsA administration caused a
preferential increase in RA without a change in Kf [5], as also
previously observed by Thompson et al [34]. Differently from FK
and CsA, acyclovir showed a distinct hemodynamic pattern, as
shown in Figure 9. Acutely the decrease in SNGFR was due to
reductions in °A and in Gc, with no changes in Kf [10]. However,
chronic administration of acyclovir caused a hemodynamic pat-
tern similar to that induced by FK chronic treatment [36, 37].
Comparative analyses of the hemodynamic patterns induced by
FK
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Fig. 2. Typical experiment showing the effect of progressive and cumulative
doses of FK 506 on [Ca2J, in mesangial cells in culture. *p < 0.02 vs.
baseline.
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Fig. 3. Typical experiment showing the effect of cumulative doses of FK 506
on [Ca27, in mesangial cells previously incubated with verapamil (VP).
CaCI2
Cad2 1.36mM
1.36mM
400 800 1,200
FK FK FK FK FK c
4i441,12345
4
VP
(5x1 0-5M)
0
C')0
1.2
0
S
1.0
0 200 800
Time, seconds
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[Ca2]1 in mesangial cells in Ca2tfree buffer and later addition of Ca Cl2 to
the solution. FK doses are: (1) i0 M; (2) 2 >< i0M; (3) 4 >< i0 M; (4)
5 x i0— M; (5) 10 M. P < 0.05 vs. FK.
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Fig. 6. Effect of the maximal FK506 dose (10—6 M) on [Ca2]1 in mesangial
cells in Ca2 tfree buffer after thapsigargin (TSG) and later addition of two
successive doses of Ca Cl2 (1.36 mM).
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Fig. 7. Effect of the maximal dose of FK 506 (10—6 M) on [Ca27, in
mesangial cells in Ca2tfree buffer after incubation with thapsigargin (TSG),
verapamil (VP) and two successive doses of CaC12 (1.36 mM).
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0 1,600 Fig. 8. Morphometry (cross sectional area-CSA) of mesangial cells in
control and after incubation with a maximal FK506 dose (10 M). Symbols
are: (U) control, N = 112; () FK506, N = 99. 6P < 0.05 vs. control.
Fig. 5. Typical experiment showing the maximal effect of FK 506 (10 M)
on [Ca2'7 in mesangial cells after incubation with thapsigargin (TSG). *p <
0.05 vs. baseline. #Phases a, b, and c are in the text.
different profiles in the microcirculation if they are administered
these three drugs suggest that they affect the renal microcircula- acutely or chronically, inducing changes in the afferent and
tion in different ways, although the common final result is a efferent arteriolar resistances that result in distinct modifications
reduction in SNGFR. Additionally, these modifications are also in the glomerular hydraulic pressures, with or without changes in
dependent on acute or chronic administration. The patterns K. Another interesting observation is that the hemodynamic
presented in Figure 9 show that CsA and acyclovir provoke profile may be qualitatively similar under acute and chronic
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mechanism, [Ca2]1 was determined and morphometric analyzes
of MC area were performed after FK treatment.
Calcium plays an important role as a transmembrane messen-
ger in the lymphocyte activation signal. Initial observations on the
relationship between extracellular Ca2 and lymphocyte activa-
tion demonstrated that early removal of Ca2 from the medium
decreased lymphocyte transformation [35—381. Additional evi-
dence for the Ca2 dependence on the initial activation signal was
observed during studies demonstrating that mitogenic lectins fail
to stimulate lymphocyte proliferation in Ca2-free medium [38,
39]. Moreover, the importance of changes in [Ca2] altering
mesangial surface area is well known and thus we decided to
evaluate the potential effect of FK on changes in [Ca2]1.
The effect of FK on the MC caused increases in [Ca2] since
the fluorescence intensity of the complex Ca2-sensitive dye
Fura-2 is directly related to the increment of [Ca2]1 [241. The
data presented in this study are expressed as the 340/380 ratio
since the determination of calcium concentration using the
Grynkiewicz's formula involves, for instance, the dissociation
constant (}(d) ofCa2 from Fura-2, which is known to be strongly
influenced by the absolute viscosity of the cytoplasm of the
different cell types [401. However, in order to provide an example
of [Ca2] concentration in molarity, values used in the represen-
tative Figures were expressed in molarity, obtained by the formula
of Grynkiewicz, Poenie and Tsien [24]. It was observed that the
increases in [Ca2] were proportional to the increases of the FK
doses (Fig. 2). It is well known that the increase of [Ca2l is due
to intracellular pool mobilization via second messenger [41] or via
Ca2 influx from the extracellular medium by membrane voltage-
dependent channels or by calcium release activating channels
(CRAC) stimulated by depletion of Ca2 from ER [27]. Typical
experiments illustrated in Figures 3 and 4 show that FK was
unable to increase [Ca2I after verapamil incubation or during
the absence of extracellular calcium in the buffer. These results
suggest that the increase in [Ca2}1 is dependent on extracellular
calcium influx via stimulation of type L voltage-dependent chan-
nels in the membrane. On the other hand, when extracellular
calcium concentration was normalized, FK significantly increased
the intensity of fluorescence (Fig. 4). However, part of this
increment could be due to the liberation of Ca2 from intracel-
lular pools, especially from the ER.
Takemura et al [27], using TSG, a blocker of Ca2-ATPase
from the ER, caused a progressive and slow depletion of Ca2 in
the ER. This event caused an increase in fluorescence intensity
until a plateau was reached, as shown in Figure 5. After awhile,
with the reduction of Ca2 from ER, a stimulus to the cytoplasm
membrane, via ionic current or via a soluble factor (CIF) [42]
induces an opening of the CRAC, thus leading to an influx of
extracellular calcium. This phenomenon was observed in our
results during the second phase shown in Figure 5, that is, the
sustained phase. Therefore, the capacitative model of Takemura
et al [27] is present in the MC. Also, after activation of CRAC, FK
was unable to further increase [Ca2]1 suggesting that this drug
could not open additional channels after a striking [Ca2]1
increase consequent to CRAC stimulation. Figure 6 shows that
MC, when incubated in the absence of calcium in the buffer, could
not present the sustained phase with TSG, since this phase is
dependent on the influx of calcium via CRAC. With the addition
of extracellular Ca2 a quick increment of [Ca2]1 was observed,
suggesting a stimulus to the cytoplasm membrane from the ER. In
SNGFR 37%*
Fig. 9. Comparative glomerular hemodynamic patterns after acute (Ac) and
chronic (Chr) administration of (A) FK 506, (B) cyclosporine (CsA) and (C)
acyclovir. Reference data are from Csa [4, 5] and acyclovir [10, 35]; data
are X ScM; *p < 0.05.
administration, as observed for FK (Fig. 9). Therefore, a compar-
ative evaluation of acute and chronic hemodynamic patterns
needs to be done in order to better understand the sequential
events in the renal microcirculation. Furthermore, the observation
of different acute and chronic hemodynamics may suggest the best
pharmacological intervention in order to minimize nephrotoxicity,
by choosing drugs that preferentially affect afferent or efferent
arterioles.
The reduction in Kf mainly observed after chronic FK admin-
istration, 42% (chronic) versus 22% (acute), suggests that me-
sangial cells may participate in this nephrotoxicity by reducing K1
(Fig. 9). To further evaluate the role of mesangial cells in this
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this situation, FK induced an additional increase in [Ca2j1,
indicating its action on membrane channels other than CRAC.
This possibility was confirmed in protocol 6 when MC were
incubated in the absence of Ca2, treated with TSG and later
incubated with verapamil. [Ca2]1 was stable but increased when
the extracellular calcium concentration was replenished, demon-
strating the CRAC effect. The addition of FK in the presence of
TSG and verapamil blunted any further increment in [Ca2], thus
confirming the hypothesis that FK acts on the voltage-dependent
channels that were blocked by verapamil (Fig. 7).
The increase in [Ca2]1 leads to many cellular functions,
including cellular contraction [411. Using morphometric analyzes,
we observed a reduction in MC surface area (Fig. 8), suggesting
that FK caused contraction of MC. Thus, it is reasonable to
suggest the occurrence of a reduction of the surface area of
glomerular ultrafiltration (reduction in Kr), in agreement with the
observations of glomerular hemodynamics in vivo. Similar obser-
vations were made by Kumano et al [43] using Diltiazem®, a
calcium channel blocker that was able to blunt the effects of FK on
the hemodynamics of rats acutely treated with FK. The present
data suggest that the contraction of MC potentially participates in
FK nephrotoxicity in vivo.
Nephrotoxicity is a complex phenomenon consisting of various
mechanisms including a variety of hormonal systems participating
in this pathophysiology that cause difficult treatment. However,
sequential studies, time- and dose-dependent studies as well as
cellular protocol studies that allow the evaluation of independent
pathways can contribute to a better understanding of nephrotox-
icity and perhaps to a more rational treatment. The nephrotoxicity
of FK may be prevented or minimized since it depends on
extracellular Ca2 mobilization, and thus Ca2 blockers could
interfere with the hemodynamic effects and also contribute to
prevention of the rejection process due to their immunosuppres-
sor activity [44].
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